Thymosin Alpha 1 · Research brief

Buy Thymosin Alpha 1 — A Research Buyer's Checklist

Real Peptides Research TeamEditorial

Updated September 16, 20269 min read

59 WORDS

Short answer

The number most labs compare first when they buy Thymosin Alpha 1 is the number that tells them the least. A vial advertised at 99% purity can still contain noticeably less actual peptide by mass than the fill weight suggests, because chromatographic purity and net peptide content describe two entirely different measurements. One says how clean the material is.

Key takeaways

Thymosin Alpha 1 is a 28-amino-acid peptide with an acetylated N-terminus, and correct mass spectrometry data on a COA reflects that acetylated mass.
HPLC purity and net peptide content are different measurements, and comparing price per milligram without accounting for salt form produces misleading cost comparisons.
A certificate of analysis is only meaningful when its lot number matches the vial you received, which is why batch-specific COA archives matter more than sample PDFs.
Thymosin Alpha 1 is not an approved drug product in the United States; research-grade material is supplied strictly for laboratory investigation.
Labs that buy Thymosin Alpha 1 from a single documented source with a consistent salt form spend far less time troubleshooting unexplained variability between experiments.
Any supplier pairing a research compound with dosing or administration language is signaling a documentation problem as much as a compliance one.

We synthesize research peptides in small batches and document every lot, so we see which purchasing questions actually predict a good outcome. They're boring questions. Which batch? Which analytical method? Which counterion? What temperature during transit?

Where can you buy Thymosin Alpha 1 for laboratory research?

Researchers buy Thymosin Alpha 1 from suppliers that publish batch-specific certificates of analysis showing HPLC purity and mass spectrometry identity confirmation for the exact lot being shipped. Thymosin Alpha 1 is a 28-amino-acid peptide supplied as a lyophilized powder, labeled for research use only. Match the COA lot number to the vial label before accepting delivery.

Here's the part the specification sheet doesn't tell you: price per milligram isn't comparable across suppliers unless both are quoting the same thing. When you buy Thymosin Alpha 1 from two vendors at the same listed fill weight, one vial may deliver appreciably more peptide than the other depending on salt form, residual solvent, and water content. This guide covers what's physically in the vial, the five documentation checks that separate a synthesizer from a reseller, and what the published literature does and doesn't say about this compound.

What the label, the salt form, and the fill weight actually mean

Thymosin Alpha 1 (Tα1, also called thymalfasin in its synthetic pharmaceutical form) is a 28-amino-acid peptide with an acetylated N-terminus, derived from the larger precursor protein prothymosin alpha. That acetyl group isn't cosmetic. It's part of the molecule's identity, and mass spectrometry on a proper certificate should reflect the acetylated mass, not the free-amine mass.

The powder in the vial is rarely 100% peptide, and no honest supplier claims otherwise. Synthetic peptides purified by reverse-phase HPLC typically carry trifluoroacetate (TFA) counterions bound to basic residues, plus bound water. Net peptide content for TFA-salt peptides commonly falls somewhere in the 70–90% range of gross mass, which is why two vials both labeled 10mg can differ in how much Tα1 they actually contain. Acetate-salt material shifts that arithmetic again.

A few label details worth reading before you order:

Sequence and modification, stated in full, including the N-terminal acetylation
Salt form, TFA or acetate, disclosed rather than left blank
Fill weight versus peptide content, ideally both reported
Appearance, a white to off-white lyophilized cake or powder
Research use only, printed on the vial itself and not just the invoice

In our experience fielding purchasing questions, the labs that get consistent results between experiments are the ones that standardize on a single salt form and track lot numbers in their notebooks. The ones that chase the lowest per-milligram price across five vendors spend more time troubleshooting variability than they save on procurement.

Where to buy Thymosin Alpha 1 without guessing about purity

Five documentation checks separate a synthesizer from a drop-shipper, and all five are visible before you spend a dollar. Ask for them by name.

1. A batch-specific certificate of analysis. Not a sample COA. Not a generic PDF with the lot field blank. The chromatogram and mass spectrum should belong to the lot in the box. Suppliers who maintain a public COA archive make this trivial to verify.

2. HPLC purity plus mass spectrometry identity. Purity tells you how much of the material is the main peak. Mass spec tells you the main peak is the right molecule. Purity alone is a claim about cleanliness, not about identity, and a correctly-run analysis reports both.

3. Net peptide content, disclosed. This is the check almost nobody performs, and it's where the real cost comparison lives. If Supplier A reports 99% HPLC purity with no peptide content figure, and Supplier B reports 98% purity with peptide content stated, Supplier B has given you more information, not less.

4. Shipping and handling conditions. Lyophilized peptides tolerate ambient transit far better than reconstituted solutions, but repeated freeze-thaw cycles and prolonged humidity exposure degrade material. A supplier who won't say how the vial travels is telling you something.

5. Clean regulatory framing. Any vendor pairing a research compound with dosing language, injection instructions, or human-use imagery is describing a product that isn't what they claim it is. That framing failure usually predicts documentation failure too.

One detail our team sees mishandled constantly: buyers compare list prices on gross fill weight while ignoring salt form entirely. Correct for peptide content first, and the cheapest listing frequently stops being the cheapest. You can see how we document this across the catalog, from Thymosin Alpha 1 through the rest of the research peptide range.

What the published literature reports, and what it doesn't

Thymosin Alpha 1 has been studied primarily as an immune-modulating peptide. Published research describes effects on T-lymphocyte maturation and differentiation, dendritic cell activation, and signaling through Toll-like receptors, which is the mechanistic basis for most of the interest in the compound. Research suggests the peptide acts as a modulator rather than a blunt stimulant, which is a meaningful distinction in immunology literature.

Its synthetic form, thymalfasin, has been marketed internationally under the trade name Zadaxin and has been evaluated in clinical settings outside the United States, including chronic hepatitis B and as a vaccine adjuvant. It has also been investigated in sepsis and critical-care contexts. Reported findings vary by population and study design, and the literature is not uniform in its conclusions.

What's equally important is the regulatory reality. Thymosin Alpha 1 is not an approved drug product in the United States, and research-grade material sold for laboratory work is not a medicine in any sense. When you buy Thymosin Alpha 1 from a research supplier, you're buying a characterized chemical for in vitro and preclinical investigation, nothing more. Nothing in this article is dosing, administration, or protocol guidance, and none of it is addressed to a person or an animal. The information here is educational, aimed at laboratory purchasing and documentation decisions.

Anyone with questions about their own health should speak with a licensed physician, and anyone with questions about an animal's health should talk to their veterinarian. Research compounds are not for human or veterinary consumption.

Sourcing routes compared: documentation, handling, and regulatory footing

This table maps the four routes labs typically encounter and what each one actually delivers on paper. The differences that matter aren't price, they're traceability and identity confirmation.

Sourcing route	Documentation typically provided	Identity verification	Regulatory framing	Bottom Line
Dedicated research peptide supplier with small-batch synthesis	Batch-specific COA with HPLC chromatogram and mass spec data, lot number matched to vial	Sequence and acetylated mass confirmed per lot	Clearly labeled research use only, no human-use language	Best traceability for repeatable experimental work; the only route where a failed batch can be traced to a specific synthesis
Generic online marketplace reseller	Generic or sample COA, lot field often blank or mismatched	Rarely lot-specific; frequently copied from an upstream source	Inconsistent, sometimes mixed with consumer-style marketing	Cheapest headline price, weakest paper trail; unsuitable when lot-to-lot consistency matters
Overseas bulk broker	Manufacturer COA of unknown provenance, limited batch linkage	Uncertain chain of custody between synthesis and shipment	Varies widely by jurisdiction and seller	Viable for large volumes if you independently test on arrival; budget for your own analytics
Compounding pharmacy route	Prescription-based, not a research supply channel	Not applicable to laboratory procurement	Clinical channel, outside research-use scope entirely	Not a comparison point for lab sourcing; different legal category, different purpose

What If: Research Procurement Scenarios

What if the certificate of analysis has no batch number?

Request the lot-specific document before the vial leaves the warehouse, and treat a refusal as a decision point. A COA without a lot number is a marketing asset, not an analytical record, because it can't be traced back to the synthesis run that produced your material. If a batch later shows unexpected behavior in assay, an unlinked COA gives you nothing to investigate. Suppliers running genuine small-batch synthesis generate a fresh chromatogram per lot and can produce it on request within a business day.

What if the vial arrives warm after a long transit?

Inspect the lyophilized cake, document the arrival condition with photographs, and contact the supplier before opening anything. Lyophilized peptides are considerably more thermally forgiving than solutions, and brief ambient exposure during shipping is normal and expected for powder. The bigger risks are moisture ingress and physical damage to the cake structure. If the powder appears melted, oily, discolored, or has collapsed into a syrup, that's a material integrity question rather than a cosmetic one.

What if the powder looks like a thin film instead of a cake?

Check the fill weight on the label before assuming the vial is underfilled. Low-milligram fills of a peptide this size often present as a barely visible film or a fine dusting on the vial wall rather than a fluffy plug, because the absolute mass is small and lyophilization geometry varies with the freeze-drying cycle. Appearance alone is a weak indicator of content. The COA is the record that answers the question.

What if two suppliers quote the same purity but very different prices?

Ask both for net peptide content and salt form, then recalculate cost per milligram of actual peptide. Price gaps at identical stated purity usually trace back to one of three things: undisclosed peptide content, a different counterion, or material that was never independently characterized at all. Our team has run this comparison across hundreds of quotes, and the ranking flips more often than buyers expect once the arithmetic is corrected.

The blunt truth about purity percentages on peptide listings

Here's the honest answer: a purity percentage on a product page, unaccompanied by a batch-linked chromatogram, is worth almost nothing. It's a number typed into a content management system. Anyone can type 99%. What can't be faked easily is a lot-specific HPLC trace with a retention time, an integration table, and a matching mass spectrum confirming the acetylated 28-residue sequence. If you only have bandwidth to check one thing before you buy Thymosin Alpha 1, skip the marketing copy entirely and go straight to the chromatogram for your lot.

For labs working across multiple compounds, the same documentation standard applies whether you're sourcing Tα1 or a structurally unrelated peptide like TB-500 (Thymosin Beta 4), and our shipping and service information sets out how material moves once a batch clears analysis.

The decision to buy Thymosin Alpha 1 is really two decisions wearing one coat: choosing a molecule, and choosing a paper trail. Researchers agonize over the first and rush the second, then spend months chasing irreproducible results that trace back to an undocumented lot swap nobody recorded. Peptide chemistry is unforgiving of vagueness. A vial with a verifiable chromatogram behind it isn't a premium feature, it's the minimum condition under which your data means anything at all six months from now, when someone asks you to repeat the experiment.

References

Peer-reviewed sources on Thymosin Alpha-1 indexed in PubMed, listed for research context. Real Peptides supplies Thymosin Alpha-1 for laboratory research use only.

Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells. Cancer research, 2026. PMID 42295795. doi:10.1158/0008-5472.CAN-25-5547
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. OncoTargets and therapy, 2025. PMID 40955371. doi:10.2147/OTT.S527785
Aging and Thymosin Alpha-1. International journal of molecular sciences, 2025. PMID 41373628. doi:10.3390/ijms262311470
Interferon-α and thymosin-α1 plus tislelizumab enhance CD8(+) T cell cytotoxicity toward pancreatic ductal adenocarcinoma. iScience, 2025. PMID 40727936. doi:10.1016/j.isci.2025.113053
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell reports. Medicine, 2024. PMID 39357524. doi:10.1016/j.xcrm.2024.101751
Enhanced Immunomodulatory Effects of Thymosin-Alpha-1 in Combination with Polyanionic Carbosilane Dendrimers against HCMV Infection. International journal of molecular sciences, 2024. PMID 38396631. doi:10.3390/ijms25041952
Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. International immunopharmacology, 2023. PMID 36812669. doi:10.1016/j.intimp.2023.109744
Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era. International immunopharmacology, 2023. PMID 36871535. doi:10.1016/j.intimp.2023.109952

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Match the lot number printed on the COA to the lot number on the vial label, then confirm the document includes both an HPLC purity chromatogram and mass spectrometry identity data. The mass spec result should correspond to the acetylated 28-amino-acid sequence, not the free-amine form. If the COA has a blank lot field or is labeled as a sample document, it isn't tied to your material.

Research-grade peptides are supplied to researchers, laboratories, and institutions for in vitro and preclinical investigation only. They are not sold for human or veterinary consumption, and suppliers operating correctly will state research-use-only status on the vial itself rather than only in the fine print. Buyers are responsible for compliance with the regulations that apply in their own jurisdiction.

Pricing varies widely with fill weight, salt form, purity specification, and how much analytical documentation the supplier generates per batch. Small-batch synthesis with lot-specific HPLC and mass spectrometry costs more to produce than bulk material shipped with a generic certificate. The more useful comparison is cost per milligram of actual peptide after correcting for net peptide content, not the headline price on the listing.

No. Thymosin Alpha 1 is not an approved drug product in the United States. Its synthetic form, thymalfasin, has been marketed under the trade name Zadaxin in a number of countries outside the US and studied in clinical settings there. Research-grade material sold by peptide suppliers is a characterized chemical for laboratory use and is not a medicine.

Lyophilized peptides are generally stored frozen and protected from light and moisture, with the specific condition stated on the supplier's certificate or product documentation. Moisture ingress is the main enemy of a lyophilized cake, so vials should be brought to room temperature before opening to avoid condensation inside the vial. Repeated freeze-thaw cycling of solutions is a common source of degradation in peptide work.

They are unrelated molecules that share a naming convention rather than a mechanism. Thymosin Alpha 1 is a 28-amino-acid acetylated peptide studied mainly in immune modulation research involving T-cell and dendritic cell activity. Thymosin Beta 4 is a longer actin-sequestering peptide investigated in tissue repair and cell migration contexts, and its fragment TB-500 is a separate research compound entirely.

Net peptide content is the percentage of the vial's gross mass that is actual peptide, with the remainder made up of counterions such as trifluoroacetate, bound water, and any residual salts. For TFA-salt peptides this commonly falls well below 100% of the stated fill weight. It is a different measurement from HPLC purity, which describes how much of the peptide present is the target molecule rather than impurities.

Lyophilized powder is substantially more tolerant of ambient transit temperatures than reconstituted solution, so short-duration shipping at room temperature is standard practice for research peptides in powder form. The variable that matters more is moisture exposure and physical protection of the cake. Reconstituted material is a different situation and requires refrigerated handling with a defined use-by window.

Thymalfasin is the international nonproprietary name for the synthetic version of Thymosin Alpha 1 used in pharmaceutical settings, marketed under the brand name Zadaxin in various countries. It is the same 28-amino-acid acetylated sequence. Research-grade Thymosin Alpha 1 supplied to laboratories is chemically the same molecule but is manufactured, labeled, and sold under a research-use-only framework rather than a pharmaceutical one.

A supplier unable or unwilling to produce a lot-specific certificate has no verifiable link between the material you received and any analytical testing. That makes troubleshooting impossible when an experiment fails, because you cannot distinguish a biological result from a material problem. Published COA archives that let you look up your lot number before or after purchase are the practical standard worth holding suppliers to.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA